BPC-157 Protocol, Dosing & Timeline

BPC-157 Overview

Mechanism of Action

BPC-157 is a 15-amino-acid synthetic peptide derived from a protective protein found in human gastric juice. It works by upregulating growth hormone receptors in tendon fibroblasts, promoting angiogenesis (new blood vessel formation) via VEGF pathways, and modulating the nitric oxide (NO) system. It also interacts with the dopaminergic system and has demonstrated cytoprotective properties across multiple organ systems.

Half-Life

Stable in gastric juice; estimated biological half-life of 4+ hours. Unlike most peptides, BPC-157 resists enzymatic degradation.

Timing

Morning administration, or split AM/PM for twice-daily protocols

Injection Site

Subcutaneous injection near the injury site when targeting a specific area, or lower abdomen for systemic/gut effects

Food

Can be administered regardless of food intake. Some practitioners recommend fasted for gut-targeted use.

Common Stacks

TB-500 — Synergistic tissue repair (the “Wolverine” stack)
GHK-Cu — Enhanced collagen synthesis and skin healing
KPV — Added anti-inflammatory and antimicrobial support

BPC-157 Dosing Protocol

Standard Protocol

4–6 weeks

250–500 mcg/day

Most common approach for general tissue repair and gut healing.

Acute Injury Loading

2–4 weeks

500 mcg 2x/day

Higher frequency for acute tendon/ligament injuries. Taper to 1x/day after initial phase.

Maintenance / Cycling

2 weeks on / 2 weeks off

250 mcg/day

Long-term support protocol. Cycling helps maintain receptor sensitivity.

BPC-157 Expected Timeline

Week 1–2

Reduced inflammation; initial pain relief at injury sites

Week 2–4

Noticeable tissue repair; improved mobility and reduced swelling

Week 4–6

Significant structural healing in tendons, ligaments, and gut lining

Week 6–8

Consolidated repair; many users report full resolution of chronic issues

BPC-157 Side Effects

Mild nausea (uncommon, typically resolves)

Injection site redness or warmth

Dizziness at higher doses (rare)

Slight fatigue during first few days (rare)

BPC-157 Research Studies

Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease

Sikiric P, Rucman R, Turkovic B, et al. — Curr Pharm Des (2018)

Comprehensive review demonstrating BPC-157’s protective effects across the GI tract, liver, and musculoskeletal tissue in multiple animal models.

PubMed: 29737246

BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts

Chang CH, Tsai WC, Lin MS, et al. — Molecules (2014)

Showed BPC-157 significantly upregulated GH receptor expression in cultured tendon cells, suggesting a key mechanism for tendon repair.

PubMed: 25257998

Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model

Sikiric P, Seiwerth S, Rucman R, et al. — J Physiol Paris (1999)

Demonstrated BPC-157’s ability to counteract NSAID-induced gastrointestinal damage and maintain mucosal integrity.

PubMed: 10574681

BPC 157 healing of colocutaneous and esophagocutaneous fistulas

Sever M, Klicek R, Radic B, et al. — J Pharmacol Sci (2009)

Showed accelerated fistula healing in rats treated with BPC-157, supporting its role in complex tissue repair scenarios.

PubMed: 19834284

BPC-157 FAQ

Should I inject BPC-157 near the injury site?

For localized injuries (tendons, joints), subcutaneous injection near the affected area can enhance local tissue concentrations. For gut healing or systemic effects, abdominal injection is standard. BPC-157 has demonstrated systemic activity regardless of injection site.

Can BPC-157 be taken orally?

Uniquely among peptides, BPC-157 is stable in gastric acid and has shown oral bioavailability in studies. Some researchers use oral administration for GI-targeted applications, though injectable remains more common for musculoskeletal use.

How does BPC-157 differ from TB-500?

BPC-157 primarily works through GH receptor upregulation and the NO system, with particular strength in gut and tendon healing. TB-500 (Thymosin Beta-4) works through actin regulation and cell migration. Together they create complementary repair pathways, which is why they are frequently combined.

Is cycling necessary?

While short-term protocols (4–6 weeks) typically don’t require cycling, longer use benefits from a 2-on/2-off pattern to maintain receptor sensitivity and allow the body’s natural repair signaling to normalize.